[The neuroleptic syndrome. Attempted systematization of primary and secondary effects observed during neuroleptic treatments].
D001247:Asthenia / Q000139:chemically induced; D001341:Autonomic Nervous System / Q000187:drug effects; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002319:Cardiovascular System / Q000187:drug effects; D002746:Chlorpromazine / Q000009:adverse effects; D003243:Consciousness / Q000187:drug effects; D003863:Depression / Q000139:chemically induced; D005128:Eye Diseases / Q000139:chemically induced; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008134:Long-Term Care; D008297:Male; D009765:Obesity / Q000139:chemically induced; D010640:Phenothiazines / Q000009:adverse effects; D010859:Pigmentation Disorders / Q000139:chemically induced; D011596:Psychomotor Disorders / Q000139:chemically induced; D012466:Salivary Gland Diseases / Q000139:chemically induced; D012735:Sexual Dysfunction, Physiological / Q000139:chemically induced; D012871:Skin Diseases / Q000139:chemically induced; D013610:Tachycardia / Q000139:chemically induced; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology
D010640:Phenothiazines; D014149:Tranquilizing Agents; D002746:Chlorpromazine
Le syndrome neuroleptique. Essais de systématisation des effets primaires et secondaires observés au cours des traitements neuroleptiques.